CSL Limited (ASX:CSL)
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
CSL Limited (ASX:CSL) share price
CSL Limited (ASX:CSL) share price news
From Hero to Xero for tech star
The benchmark S&P/ASX 200 (INDEXASX: XJO) index advanced 19.5 points, or 0.3%, to 7014.9, while the broader All Ordinaries (INDEXASX: XAO) index rose 16.7 points, or 0.2%, to 7,215.
Waiting on a rates decision
The S&P/ASX 200 (INDEXASX: XJO) closed 19.2 points, or 0.3%, higher at 6,997 and the broader All Ordinaries (INDEXASX: XAO) index was 0.2% higher, up 17.2 points at 7,192.3.
All Ordinaries (INDEXASX:XAO) jumps on Regal acquisition: GQG bids for parent
The Australian share market staged a strong rally to begin November, with the S&P/ASX 200 (INDEXASX: XJO) gaining 0.9% and the All Ordinaries (INDEXASX: XAO) 0.8% as just two of the 11 sectors posted losses.
Kate & Owen pull apart the ASX’s 10 largest companies: BHP, CBA, CSL & more!
This episode gives you an overview of the 10 LARGEST Australian companies that feature heavily in many core ETFs (for example, VAS, A200, IOX & STW).
Inflation surprise halts Australian indices in their tracks
The benchmark S&P/ASX 200 (INDEXASX: XJO) closed 2.6 points lower, at 6,854, losing early gains. The broader All Ordinaries (INDEXASX: XAO) index, however, managed a 0.7-point gain, to 7,046.
Miners lead Aussie market higher
The benchmark S&P/ASX 200 (INDEXASX: XJO) index added 12.8 points, or 0.2%, to 6,856, while the broader All Ordinaries (INDEXASX: XAO) index gained 15.6 points, or 0.2%, to 7,045.
Australian share market turns red for 2023
The Australian stock market has given up all of the gains that it had made in 2023, with the benchmark S&P/ASX 200 (INDEXASX: XJO) losing 56.6 points, or 0.8%, on Monday to 6,844.1, with resources weakness the major culprit. That puts the index in the red by 2.8% for the year.
3 things that got the team at Firetrail talking at Week 3 of October
CSL Limited (ASX: CSL) is currently trading at a 1-yr forward PE of 24x, a 40% premium to the ASX Industrials. 24x puts it on the same multiple as defensives like Woolworths Group Ltd (ASX: WOW), Wesfarmers Ltd (ASX: WES) and Sonic Healthcare Ltd (ASX: SHL), for ~2-3x the earnings growth!
ResMed and CSL shares are cheap & Tesla’s cyber truck is coming to Australia?
Will Ozempic sink ResMed Inc (ASX:RMD) and CSL Limited (ASX:CSL)? Will Tesla’s Cyber Truck come to Australia? The Australian Investors Podcast explains…